Skip to main content
Top
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Herpes Virus | Research

Vitamin D serum level in participants with positive history of recurrent herpes labialis

Authors: Zahra Ranjbar, Fatemeh Lavaee, Maryam Karandish, Farnaz Peiravian, Fateme Zarei

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

Aim

Vitamin D plays an important role in immune system regulation, also its deficiency is assumed to affect the patients’ predisposition to viral diseases such as recurrent herpes labialis. In this cross-sectional study, we tried to compare the mean serum level of vitamin D in participants with a positive history of recurrent herpes labial lesions and healthy controls.

Materials and methods

The vitamin D serum level of 43 participants with a positive history of recurrent herpes labial lesions who were referred to the Motahhari laboratory in Shiraz during 2020–2022, was compared with 42 healthy controls. It was assessed by an Elisa kit. An Independent T-test was used to compare the vitamin D serum level between two genders. In order to assess the mean age value and gender distribution, an independent T-test and Pearson Chi-Square were used, respectively for the two groups. The serum vitamin D level was compared between both control and test groups.

Results

There was no significant difference between vitamin D mean serum levels in the two evaluated groups (p.value = 0.72). Although the age (p.value = 0.09) and recurrence (p.value = 0.13) of herpes labialis had no statistically significant relation to the vitamin D serum level, the healing duration of herpes labialis was inversely related (p.value = 0.01). Lower-level of serum vitamin D were accompanied by a longer healing duration of the lesions.

Conclusion

Although the vitamin D serum level of participants with a history of recurrent herpes labialis had no relation with age and herpes virus recurrence frequency, a longer healing duration of lesions had been reported in patients with lower serum levels of vitamin D.
Literature
1.
go back to reference Ranjbar Z, Zahed M, Ranjbar MA, Shirmardan Z. Comparative study of serum zinc concentration in recurrent herpes labialis patients and healthy individuals. BMC Oral Health. 2020;20(1):296.CrossRefPubMedPubMedCentral Ranjbar Z, Zahed M, Ranjbar MA, Shirmardan Z. Comparative study of serum zinc concentration in recurrent herpes labialis patients and healthy individuals. BMC Oral Health. 2020;20(1):296.CrossRefPubMedPubMedCentral
3.
go back to reference Golestannejad Z, Khozeimeh F, Mehrasa M, Mirzaeei S, Sarfaraz D. A novel drug delivery system using acyclovir nanofiber patch for topical treatment of recurrent herpes labialis: A randomized clinical trial. Clin Exp Dent Res. 2021. Golestannejad Z, Khozeimeh F, Mehrasa M, Mirzaeei S, Sarfaraz D. A novel drug delivery system using acyclovir nanofiber patch for topical treatment of recurrent herpes labialis: A randomized clinical trial. Clin Exp Dent Res. 2021.
4.
go back to reference Lavaee F, Shahrokhi Sardo M, Zarei F, Shahrokhi Sardo M. Comparison of serum and dietary selenium levels in participants with a positive history of recurrent herpes lesions and healthy individuals. Biomed Res Int. 2021;2021:6083716.CrossRefPubMedPubMedCentral Lavaee F, Shahrokhi Sardo M, Zarei F, Shahrokhi Sardo M. Comparison of serum and dietary selenium levels in participants with a positive history of recurrent herpes lesions and healthy individuals. Biomed Res Int. 2021;2021:6083716.CrossRefPubMedPubMedCentral
5.
go back to reference Polizzi A, Santonocito S, Lo Giudice A, Alibrandi A, De Pasquale R, Isola G. Analysis of the response to two pharmacological protocols in patients with oral lichen planus: A randomized clinical trial. Oral Diseases. 2021. Polizzi A, Santonocito S, Lo Giudice A, Alibrandi A, De Pasquale R, Isola G. Analysis of the response to two pharmacological protocols in patients with oral lichen planus: A randomized clinical trial. Oral Diseases. 2021.
6.
go back to reference Santonocito S, Polizzi A, De Pasquale R, Ronsivalle V, Lo Giudice A, Isola G. Analysis of the efficacy of two treatment protocols for patients with symptomatic oral lichen planus: a randomized clinical trial. Int J Environ Res Public Health. 2021;18(1):56.CrossRef Santonocito S, Polizzi A, De Pasquale R, Ronsivalle V, Lo Giudice A, Isola G. Analysis of the efficacy of two treatment protocols for patients with symptomatic oral lichen planus: a randomized clinical trial. Int J Environ Res Public Health. 2021;18(1):56.CrossRef
7.
go back to reference Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003;49(2):277–300.PubMed Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003;49(2):277–300.PubMed
8.
go back to reference Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol. 2004;34(4):1068–76.CrossRefPubMed Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol. 2004;34(4):1068–76.CrossRefPubMed
9.
go back to reference Sali S, Tavakolpour S, Farkhondemehr B. Comparison of vitamin D levels in naive, treated, and inactive carriers with chronic Hepatitis B Virus. J Clin Transl Hepatol. 2016;4(4):306–9.CrossRefPubMedPubMedCentral Sali S, Tavakolpour S, Farkhondemehr B. Comparison of vitamin D levels in naive, treated, and inactive carriers with chronic Hepatitis B Virus. J Clin Transl Hepatol. 2016;4(4):306–9.CrossRefPubMedPubMedCentral
10.
go back to reference Zitt E, Sprenger-Mähr H, Knoll F, Neyer U, Lhotta K. Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease. Vaccine. 2012;30(5):931–5.CrossRefPubMed Zitt E, Sprenger-Mähr H, Knoll F, Neyer U, Lhotta K. Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease. Vaccine. 2012;30(5):931–5.CrossRefPubMed
11.
go back to reference Lewis JA, Jonsson B, Kreutz G, Sampaio C, van Zwieten-Boot B. Placebo-controlled trials and the declaration of Helsinki. The Lancet. 2002;359(9314):1337–40.CrossRef Lewis JA, Jonsson B, Kreutz G, Sampaio C, van Zwieten-Boot B. Placebo-controlled trials and the declaration of Helsinki. The Lancet. 2002;359(9314):1337–40.CrossRef
12.
go back to reference Ike AC, Onu CJ, Ononugbo CM, Reward EE, Muo SO. Immune Response to Herpes Simplex Virus Infection and Vaccine Development. Vaccines (Basel). 2020;8(2). Ike AC, Onu CJ, Ononugbo CM, Reward EE, Muo SO. Immune Response to Herpes Simplex Virus Infection and Vaccine Development. Vaccines (Basel). 2020;8(2).
13.
go back to reference Takahashi K, Nakayama Y, Horiuchi H, Ohta T, Komoriya K, Ohmori H, et al. Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25-dihydroxyvitamin D3. Immunopharmacol Immunotoxicol. 2002;24(3):335–47.CrossRefPubMed Takahashi K, Nakayama Y, Horiuchi H, Ohta T, Komoriya K, Ohmori H, et al. Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25-dihydroxyvitamin D3. Immunopharmacol Immunotoxicol. 2002;24(3):335–47.CrossRefPubMed
15.
go back to reference Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004;229(11):1136–42.CrossRefPubMed Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004;229(11):1136–42.CrossRefPubMed
16.
go back to reference Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol. 2010;184(2):965–74.CrossRefPubMed Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol. 2010;184(2):965–74.CrossRefPubMed
18.
go back to reference Wang G, Mishra B, Epand RF, Epand RM. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Biochim Biophys Acta. 2014;1838(9):2160–72.CrossRefPubMedPubMedCentral Wang G, Mishra B, Epand RF, Epand RM. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Biochim Biophys Acta. 2014;1838(9):2160–72.CrossRefPubMedPubMedCentral
19.
21.
go back to reference Holick MF, Schnoes HK, DeLuca HF, Suda T, Cousins RJ. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry. 1971;10(14):2799–804.CrossRefPubMed Holick MF, Schnoes HK, DeLuca HF, Suda T, Cousins RJ. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry. 1971;10(14):2799–804.CrossRefPubMed
22.
go back to reference Bi Y, Zhang W, Sun J, Gao R. Therapeutic and immune function improvement of vitamin D combined with IFN-α on mouse with hepatitis B infection. Int J Immunopathol Pharmacol. 2018;32:2058738418775250.CrossRefPubMedPubMedCentral Bi Y, Zhang W, Sun J, Gao R. Therapeutic and immune function improvement of vitamin D combined with IFN-α on mouse with hepatitis B infection. Int J Immunopathol Pharmacol. 2018;32:2058738418775250.CrossRefPubMedPubMedCentral
23.
go back to reference Kriesel JD, Spruance J. Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine. 1999;17(15–16):1883–8.CrossRefPubMed Kriesel JD, Spruance J. Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine. 1999;17(15–16):1883–8.CrossRefPubMed
24.
go back to reference Goncalves-Mendes N, Talvas J, Dualé C, Guttmann A, Corbin V, Marceau G, et al. Impact of vitamin D supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: a randomized placebo-controlled trial. Front Immunol. 2019;10:65.CrossRefPubMedPubMedCentral Goncalves-Mendes N, Talvas J, Dualé C, Guttmann A, Corbin V, Marceau G, et al. Impact of vitamin D supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: a randomized placebo-controlled trial. Front Immunol. 2019;10:65.CrossRefPubMedPubMedCentral
25.
go back to reference Principi N, Marchisio P, Terranova L, Zampiero A, Baggi E, Daleno C, et al. Impact of vitamin D administration on immunogenicity of trivalent inactivated influenza vaccine in previously unvaccinated children. Hum Vaccin Immunother. 2013;9(5):969–74.CrossRefPubMedPubMedCentral Principi N, Marchisio P, Terranova L, Zampiero A, Baggi E, Daleno C, et al. Impact of vitamin D administration on immunogenicity of trivalent inactivated influenza vaccine in previously unvaccinated children. Hum Vaccin Immunother. 2013;9(5):969–74.CrossRefPubMedPubMedCentral
27.
go back to reference Zdrenghea MT, Makrinioti H, Bagacean C, Bush A, Johnston SL, Stanciu LA. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. 2017;27(1). Zdrenghea MT, Makrinioti H, Bagacean C, Bush A, Johnston SL, Stanciu LA. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. 2017;27(1).
28.
go back to reference Holmøy T. Vitamin D status modulates the immune response to Epstein Barr virus: synergistic effect of risk factors in multiple sclerosis. Med Hypotheses. 2008;70(1):66–9.CrossRefPubMed Holmøy T. Vitamin D status modulates the immune response to Epstein Barr virus: synergistic effect of risk factors in multiple sclerosis. Med Hypotheses. 2008;70(1):66–9.CrossRefPubMed
29.
go back to reference Mandorfer M, Payer BA, Schwabl P, Steiner S, Ferlitsch A, Aichelburg MC, et al. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3. Liver Int. 2015;35(3):876–85.CrossRefPubMed Mandorfer M, Payer BA, Schwabl P, Steiner S, Ferlitsch A, Aichelburg MC, et al. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3. Liver Int. 2015;35(3):876–85.CrossRefPubMed
30.
go back to reference Smith EM, Alvarez JA, Kearns MD, Hao L, Sloan JH, Konrad RJ, et al. High-dose vitamin D(3) reduces circulating hepcidin concentrations: a pilot, randomized, double-blind, placebo-controlled trial in healthy adults. Clin Nutr. 2017;36(4):980–5.CrossRefPubMed Smith EM, Alvarez JA, Kearns MD, Hao L, Sloan JH, Konrad RJ, et al. High-dose vitamin D(3) reduces circulating hepcidin concentrations: a pilot, randomized, double-blind, placebo-controlled trial in healthy adults. Clin Nutr. 2017;36(4):980–5.CrossRefPubMed
31.
go back to reference Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys. 2000;374(2):334–8.CrossRefPubMed Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys. 2000;374(2):334–8.CrossRefPubMed
32.
33.
go back to reference Prietl B, Pilz S, Wolf M, Tomaschitz A, Obermayer-Pietsch B, Graninger W, et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J. 2010;12(3):136–9.PubMed Prietl B, Pilz S, Wolf M, Tomaschitz A, Obermayer-Pietsch B, Graninger W, et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J. 2010;12(3):136–9.PubMed
34.
go back to reference Aloia JF, Clinical Review. The 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin Endocrinol Metab. 2011;96(10):2987–96.CrossRefPubMed Aloia JF, Clinical Review. The 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin Endocrinol Metab. 2011;96(10):2987–96.CrossRefPubMed
35.
go back to reference Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.CrossRefPubMed Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.CrossRefPubMed
36.
go back to reference Lesko LJ, Atkinson A Jr. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol. 2001;41(1):347–66.CrossRefPubMed Lesko LJ, Atkinson A Jr. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol. 2001;41(1):347–66.CrossRefPubMed
37.
go back to reference Vostal JG, Buehler PW, Gelderman MP, Alayash AI, Doctor A, Zimring JC et al. Proceedings of the Food and Drug Administration’s public workshop on new red blood cell product regulatory science 2016. Transfusion. 2018;58(1):255 – 66. Vostal JG, Buehler PW, Gelderman MP, Alayash AI, Doctor A, Zimring JC et al. Proceedings of the Food and Drug Administration’s public workshop on new red blood cell product regulatory science 2016. Transfusion. 2018;58(1):255 – 66.
38.
go back to reference Martellacci L, Quaranta G, Patini R, Isola G, Gallenzi P, Masucci L. A literature review of metagenomics and culturomics of the peri-implant microbiome: current evidence and future perspectives. Materials. 2019;12(18):3010.CrossRefPubMedPubMedCentral Martellacci L, Quaranta G, Patini R, Isola G, Gallenzi P, Masucci L. A literature review of metagenomics and culturomics of the peri-implant microbiome: current evidence and future perspectives. Materials. 2019;12(18):3010.CrossRefPubMedPubMedCentral
39.
go back to reference Rojo D, Méndez-García C, Raczkowska BA, Bargiela R, Moya A, Ferrer M, et al. Exploring the human microbiome from multiple perspectives: factors altering its composition and function. FEMS Microbiol Rev. 2017;41(4):453–78.CrossRefPubMedPubMedCentral Rojo D, Méndez-García C, Raczkowska BA, Bargiela R, Moya A, Ferrer M, et al. Exploring the human microbiome from multiple perspectives: factors altering its composition and function. FEMS Microbiol Rev. 2017;41(4):453–78.CrossRefPubMedPubMedCentral
40.
go back to reference Liu WM, Nahar TE, Jacobi RH, Gijzen K, van Beek J, Hak E, et al. Impaired production of TNF-α by dendritic cells of older adults leads to a lower CD8 + T cell response against influenza. Vaccine. 2012;30(9):1659–66.CrossRefPubMed Liu WM, Nahar TE, Jacobi RH, Gijzen K, van Beek J, Hak E, et al. Impaired production of TNF-α by dendritic cells of older adults leads to a lower CD8 + T cell response against influenza. Vaccine. 2012;30(9):1659–66.CrossRefPubMed
41.
go back to reference Gallagher JC. Vitamin D and aging. Endocrinol Metabolism Clin. 2013;42(2):319–32.CrossRef Gallagher JC. Vitamin D and aging. Endocrinol Metabolism Clin. 2013;42(2):319–32.CrossRef
Metadata
Title
Vitamin D serum level in participants with positive history of recurrent herpes labialis
Authors
Zahra Ranjbar
Fatemeh Lavaee
Maryam Karandish
Farnaz Peiravian
Fateme Zarei
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Herpes Virus
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-02924-0

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue